"Modafinil use in patients with a primary psychiatric illness." Australian and New Zealand Journal of Psychiatry, 44(6), pp. 583–584
Acknowledgements
Development of “Modafinil use in patients with a primary psychiatric illness” has been supported by an educational grant from CSL Biotherapies, with editorial support provided by Karyn Weitzner, Lifeblood, Camperdown, NSW, Australia.
Declaration of interest: The contributing authors have not received any financial incentives from CSL Biotherapies in the development of this manuscript.